Trials / Completed
CompletedNCT02565069
Identification for the Treatment of Complex Arrhythmias
Identification for the Treatment of Complex Arrhythmias (CartoFinder™ Algorithm Trial: "CF163 EU")
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 70 (actual)
- Sponsor
- Biosense Webster, Inc. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary purpose of this trial is to demonstrate that the utilization of CartoFinder™ 4D Local Activation Time (LAT) Algorithm may help identify and improve the outcome for the treatment of complex arrhythmias.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CartoFinder™ Device with CARTO® 3 System V5 Navigation | Ablation treatment |
Timeline
- Start date
- 2015-07-01
- Primary completion
- 2017-01-24
- Completion
- 2018-01-24
- First posted
- 2015-10-01
- Last updated
- 2025-02-03
Source: ClinicalTrials.gov record NCT02565069. Inclusion in this directory is not an endorsement.